Cytomegalovirus seropositivity and incident ischaemic heart disease in the Caerphilly prospective heart disease study

Heart

Volumn 81, Issue 3, 1999, Pages 248-251

  Strachan, D P ^a   Carrington, D ^a   Mendall, M A ^a   Butland, B K ^a   Sweetnam, P M ^b   Elwood, P C ^b  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b LLANDOUGH HOSPITAL   (United Kingdom)

Author keywords

Atherosclerosis; Coronary artery disease; Cytomegalovirus

Indexed keywords

VIRUS ANTIBODY;

ADULT; ANTIBODY TITER; ARTICLE; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; CYTOMEGALOVIRUS INFECTION; DISEASE ASSOCIATION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SERODIAGNOSIS; VIRUS INFECTION;

EID: 0033009091     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.81.3.248     Document Type: Article

References (23)

1. Melnick JL, Petrie BL, Dreesman GR, et al. Cytomegalovirus antigen within human arterial smooth muscle cells. Lancet 1983;ii:644-7.
2. Hendrix MGR, Salimans MMM, van Boven CPA, et al. High prevalence of latently present cytomegalovirus in arterial walls of patients suffering from grade III atherosclerosis. Am J Pathol 1989;136:23-8.
3. Melnick JL, Hu C, Burek J, et al. Cytomegalovirus DNA in arterial walls of patients with atherosclerosis. J Med Virol 1904;42:170-4.
4. Hendrix MG, Daemen M, Bruggeman CA. Cytomegalovirus nucleic acid distribution within the human vascular tree. Am J Pathol 1991;138:563-7.
5. Adam E, Melnick JL, Probtsfield JL, et al. High levels of cytomegalovirus antibody in patients requiring vascular surgery for atherosclerosis. Lancet 1987;ii:291-3.
6. Sorlie PD, Adam E, Melnick SL, et al. Cytomegalovirus, herpesvirus and carotid atherosclerosis: the ARIC study. J Med Virol 1994;42:33-7.
7. Nieto FJ, Adam E, Sorlie P, et al. Cohort study of cytomegalovirus infection as a risk factor for carotid intimal thickening, a measure of subclinical atherosclerosis. Circulation 1996;94:922-7.
8. Danesh J, Collins R, Peto R. Chronic infections and coronary heart disease: is there a link? Lancet 1997;350:430-6.
9. Speir E, Modali R, Huang ES, et al. Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science 1994;265:391-4.
10. Gulizia JM, Kandolf R, Kendall TJ, et al. Infrequency of cytomegalovirus genome in coronary arteriopathy of human heart allografts. Am J Pathol 1995;147:461-75.
11. Dummer S, Lee A, Breinig MK, et al. Investigation of cytomegalovirus infection as a risk factor for coronary atheosclerosis in the explanted hearts of patients undergoing heart transplantation. J Med Virol 1994;44:305-9.
12. Cour MI, Lopez de Atalaya FJ, Palau L, et al. Lack of serological association between herpesvirus and atherosclerosis. Lancet 1989;i:279.
13. Ossewaarde JM, Feskens EJM, de Vries A, et al. Chlamydia pneumoniae is a risk factor for coronary heart disease in symptom-free elderly men, but Helicobacter pylori and cytomegalovirus are not. Epidemiol Infect 1998;120:93-9.
14. The Caerphilly and Speedwell Collaborative Group. The Caerphilly and Speedwell collaborative heart disease studies. J Epidemiol Community Health 1984;38:259-62.
15. Bainton D, Miller NC, Bolton CH, et al. Plasma triglyceride and high density lipoprotein cholesterol as predictors of ischaemic heart disease in British men. Br Heart J 1992;68: 60-6.
16. Yarnell JWG, Baker IA, Sweetnam PM, al. Fibrinogen, viscosity and white blood cell count are major risk factors for ischaemic heart disease. The Caerphilly and Speedwell collaborative heart disease studies. Circulation 1991;83: 836-44.
17. Office of Population Censuses and Surveys. Classification of occupations. London: HMSO, 1980.
18. Booth JC, Hannington G, Aziz TAG, et al. Comparison of enzyme-linked immunosorbent assay (ELISA) technique and complement-fixation test for estimation of cytomegalovirus IgG antibody. J Clin Pathol 1979;32:122-7.
19. Booth JC, Hannington G, Bakir TMF, et al. Comparison of enzyme-linked immunosorbent assay, radioimmunoassay, complement fixation, anticomplement immunofluorescence and passive haemagglutination techniques for detecting cytomegalovirus IgG antibody. J Clin Pathol 1982;35:1345-8.
20. Stata Corporation. STATA reference manual: release 3.1, 6th ed. College Station, Texas: Stata Corporation, 1993.
21. Griffiths PD. Chronic cytomegalovirus infection. J Virol Methods 1988;21:79-86.
22. Krech U. Complement-fixing antibodies against cytomegalovirus in different parts of the world. Bull WHO 1973;49: 103-6.
23. Yarnell JWG, Milbank JF, Munro JA, et al. The prevalence of cytomegalovirus antibody in women: an epidemiological study from south Wales. Public Health 1982;96: 251-5.